Discovery and Characterization of CD12681, a Potent RORγ Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis

0 avis

Discovery and Characterization of CD12681, a Potent RORγ Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis

Archive ouverte

Edité par CCSD ; Wiley-VCH Verlag -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Sulfoximines as potent RORγ inverse agonists

Archive ouverte | Ouvry, Gilles | CCSD

International audience

Discovery and process development of a novel TACE inhibitor for the topical treatment of psoriasis

Archive ouverte | Boiteau, Jean-Guy | CCSD

International audience. Targeting the TNFα pathway is a validated approach to the treatment of psoriasis. In this pathway, TACE stands out as a druggable target and has been the focus of in-house research programs. ...

A Subset of Type I Conventional Dendritic Cells Controls Cutaneous Bacterial Infections through VEGF alpha-Mediated Recruitment of Neutrophils

Archive ouverte | Janela, Baptiste | CCSD

International audience. Skin conventional dendritic cells (cDCs) exist as two distinct subsets, cDC1s and cDC2s, which maintain the balance of immunity to pathogens and tolerance to self and microbiota. Here, we exa...

Chargement des enrichissements...